23andMe resurrected

For most people, 23andMe is synonymous with direct-to-consumer genomics. It isn’t DNA sequencing, it’s microarrays that are capable of detecting many annotated variants. As with all direct-to-consumer genomics, the cost to consumers was supposed to be subsidized by the aftermarket for genetic information. In the event, 23andMe declared bankruptcy recently, and there was a question […]